Locations:
Search IconSearch
December 14, 2018/Cancer/News & Insight

Givers and Takers: Understanding the Players on Your Cancer Team

Why some teams work better than others

dr-team_650x450

Teamwork wasn’t taught in med school, says Brian Bolwell, MD, Chair of Physician Leadership and Development and former Chair of Taussig Cancer Institute. Taking tests was individualistic. So was passing boards. CVs highlight one person, not a team.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Yet one of the keys to a successful cancer center is generating and sustaining high-functioning teams, he says. There are clinical teams dedicated to a disease specialty. There are nursing teams, research teams, quality and compliance teams, and more.

In his quest to understand why some teams work better than others, Dr. Bolwell read Give and Take, a book about organizational leadership by Adam Grant. From it, he gleaned two truths “immediately relevant to all of us.”

Read more in Dr. Bolwell’s editorial “Givers and Takers” in Oncology Times.

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad